Based on a recent publication evaluating several leading cancer mutation databases, KRAS is by far the most commonly mutated of the three RAS genes in solid tumours (75%), followed by NRAS (17%) and HRAS (7%) [13]. This evidence concerns the gene HRAS and cancer.